Prodigy spinal cord stimulation system gets CE mark approval

Error message

Notice: Undefined property: stdClass::$comment_count in comment_node_page_additions() (line 728 of /home/www/af6fb460493826639bb2dc594fd1d05c/web/modules/comment/comment.module).

Burst technology expands treatment options for patients suffering from chronic pain and provides significant relief so they can reclaim their quality of life,” says Dirk De Ridder, neurological professor of Neurosurgery, from the University of Otago in Dunedin, New Zealand. “Prodigy’s pioneering stimulation mode allows me to tune therapy to my patient’s unique pain condition. Burst holds promise to fill the void where alternative stimulation modes fail to control patients’ pain or for those who lose therapeutic benefit over time.”

St Jude Medical’s new burst technology offers intermittent “bursts” of stimulation designed to provide an alternative therapy method for chronic conditions such as back pain. In addition, burst stimulation has been demonstrated to minimise paraesthesia in some patients which can often fluctuate with posture and body position changes. Early evidence suggests that by enabling the delivery of both modes of stimulation, clinicians can more effectively adjust therapy to address the patient’s unique pain condition.

The Prodigy system features the longest-lasting battery life, even at the highest settings, of any rechargeable spinal cord stimulation device in its class. Additionally, its small size allows for a smaller incision, which gives physicians increased flexibility in selecting the implant location and is intended to make the site less visible and more comfortable for patients.

Through an Investigational Device Exemption from the US Food and Drug Administration (FDA), the St. Jude Medical study called SUNBURST (Success using neuromodulation with burst) is evaluating whether burst stimulation can be more effective in managing chronic pain than traditional tonic stimulation. (source : Neuronews)